Producer T cells: Using genetically engineered T cells as vehicles to generate and deliver therapeutics to tumors
about
Balanced secretion of anti-CEA × anti-CD3 diabody chains using the 2A self-cleaving peptide maximizes diabody assembly and tumor-specific cytotoxicity.T-lymphocyte homing: an underappreciated yet critical hurdle for successful cancer immunotherapy.CAR T-cell therapy of solid tumors.Immunological Approaches Towards Cancer and Inflammation: A Cross Talk.
P2860
Producer T cells: Using genetically engineered T cells as vehicles to generate and deliver therapeutics to tumors
description
2016 nî lūn-bûn
@nan
2016 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Producer T cells: Using geneti ...... deliver therapeutics to tumors
@ast
Producer T cells: Using geneti ...... deliver therapeutics to tumors
@en
Producer T cells: Using geneti ...... deliver therapeutics to tumors
@nl
type
label
Producer T cells: Using geneti ...... deliver therapeutics to tumors
@ast
Producer T cells: Using geneti ...... deliver therapeutics to tumors
@en
Producer T cells: Using geneti ...... deliver therapeutics to tumors
@nl
prefLabel
Producer T cells: Using geneti ...... deliver therapeutics to tumors
@ast
Producer T cells: Using geneti ...... deliver therapeutics to tumors
@en
Producer T cells: Using geneti ...... deliver therapeutics to tumors
@nl
P2860
P1433
P1476
Producer T cells: Using geneti ...... deliver therapeutics to tumors
@en
P2093
Alexander K Tsai
Eduardo Davila
P2860
P304
P356
10.1080/2162402X.2015.1122158
P407
P577
2016-05-01T00:00:00Z